Ohmoto A - Search Results

1

Clinicopathologic Features and Germline Sequence Variants in Young Patients (≤40 Years Old) With Pancreatic Ductal Adenocarcinoma.

Ohmoto A, Yachida S, Kubo E, Takai E, Suzuki M, Shimada K, Okusaka T, Morizane C. Ohmoto A, et al. Pancreas. 2016 Aug;45(7):1056-61. doi: 10.1097/MPA.0000000000000574. Pancreas. 2016. PMID: 26692440

2

Germline mutations in Japanese familial pancreatic cancer patients.

Takai E, Yachida S, Shimizu K, Furuse J, Kubo E, Ohmoto A, Suzuki M, Hruban RH, Okusaka T, Morizane C, Furukawa T. Takai E, et al. Among authors: ohmoto a. Oncotarget. 2016 Nov 8;7(45):74227-74235. doi: 10.18632/oncotarget.12490. Oncotarget. 2016. PMID: 27732944 Free PMC article.

3

Pancreatic Neuroendocrine Neoplasms: Basic Biology, Current Treatment Strategies and Prospects for the Future.

Ohmoto A, Rokutan H, Yachida S. Ohmoto A, et al. Int J Mol Sci. 2017 Jan 13;18(1):143. doi: 10.3390/ijms18010143. Int J Mol Sci. 2017. PMID: 28098761 Free PMC article. Review.

4

Current status of poly(ADP-ribose) polymerase inhibitors and future directions.

Ohmoto A, Yachida S. Ohmoto A, et al. Onco Targets Ther. 2017 Oct 26;10:5195-5208. doi: 10.2147/OTT.S139336. eCollection 2017. Onco Targets Ther. 2017. PMID: 29138572 Free PMC article. Review.

5

Germline variants in pancreatic cancer patients with a personal or family history of cancer fulfilling the revised Bethesda guidelines.

Ohmoto A, Morizane C, Kubo E, Takai E, Hosoi H, Sakamoto Y, Kondo S, Ueno H, Shimada K, Yachida S, Okusaka T. Ohmoto A, et al. J Gastroenterol. 2018 Oct;53(10):1159-1167. doi: 10.1007/s00535-018-1466-y. Epub 2018 Apr 17. J Gastroenterol. 2018. PMID: 29667044

6

Establishment of preclinical chemotherapy models for gastroenteropancreatic neuroendocrine carcinoma.

Ohmoto A, Suzuki M, Takai E, Rokutan H, Fujiwara Y, Morizane C, Yanagihara K, Shibata T, Yachida S. Ohmoto A, et al. Oncotarget. 2018 Apr 20;9(30):21086-21099. doi: 10.18632/oncotarget.24930. eCollection 2018 Apr 20. Oncotarget. 2018. PMID: 29765522 Free PMC article.

7

Genomic Features and Clinical Management of Patients with Hereditary Pancreatic Cancer Syndromes and Familial Pancreatic Cancer.

Ohmoto A, Yachida S, Morizane C. Ohmoto A, et al. Int J Mol Sci. 2019 Jan 29;20(3):561. doi: 10.3390/ijms20030561. Int J Mol Sci. 2019. PMID: 30699894 Free PMC article. Review.

8

Correction: Establishment of preclinical chemotherapy models for gastroenteropancreatic neuroendocrine carcinoma.

Ohmoto A, Suzuki M, Takai E, Rokutan H, Fujiwara Y, Morizane C, Yanagihara K, Shibata T, Yachida S. Ohmoto A, et al. Oncotarget. 2019 Sep 10;10(52):5494. doi: 10.18632/oncotarget.27199. eCollection 2019 Sep 10. Oncotarget. 2019. PMID: 31534635 Free PMC article.

9

Genomic Profiles and Current Therapeutic Agents in Neuroendocrine Neoplasms.

Ohmoto A, Morizane C. Ohmoto A, et al. Curr Drug Targets. 2020;21(4):389-405. doi: 10.2174/1389450119666191014105211. Curr Drug Targets. 2020. PMID: 31633473 Review.

10

Whole-exome Sequencing Reveals New Potential Susceptibility Genes for Japanese Familial Pancreatic Cancer.

Takai E, Nakamura H, Chiku S, Kubo E, Ohmoto A, Totoki Y, Shibata T, Higuchi R, Yamamoto M, Furuse J, Shimizu K, Takahashi H, Morizane C, Furukawa T, Yachida S. Takai E, et al. Among authors: ohmoto a. Ann Surg. 2022 Apr 1;275(4):e652-e658. doi: 10.1097/SLA.0000000000004213. Ann Surg. 2022. PMID: 32826389

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

83 results

Search Page

Filters